These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27852071)

  • 21. CD10 inhibits cell motility but expression is associated with advanced stage disease in colorectal cancer.
    Raposo TP; Comes MS; Idowu A; Agit B; Hassall J; Fadhil W; Nica R; Ecker R; Yao T; Ilyas M
    Exp Mol Pathol; 2018 Jun; 104(3):190-198. PubMed ID: 29653092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition.
    Feng M; Feng J; Chen W; Wang W; Wu X; Zhang J; Xu F; Lai M
    Mol Cancer; 2016 Dec; 15(1):77. PubMed ID: 27912767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of IFITM1 and IFITM3 gene deletion on IFNγ stimulated protein synthesis.
    Gómez-Herranz M; Nekulova M; Faktor J; Hernychova L; Kote S; Sinclair EH; Nenutil R; Vojtesek B; Ball KL; Hupp TR
    Cell Signal; 2019 Aug; 60():39-56. PubMed ID: 30951861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epithelial to mesenchymal transition might be induced via CD44 isoform switching in colorectal cancer.
    Mashita N; Yamada S; Nakayama G; Tanaka C; Iwata N; Kanda M; Kobayashi D; Fujii T; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
    J Surg Oncol; 2014 Nov; 110(6):745-51. PubMed ID: 24975268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells.
    Takahashi Y; Sawada G; Kurashige J; Matsumura T; Uchi R; Ueo H; Ishibashi M; Takano Y; Akiyoshi S; Iwaya T; Eguchi H; Sudo T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Anticancer Res; 2013 May; 33(5):1927-34. PubMed ID: 23645740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of IFITM1 enhances the inhibiting effect of caveolin-1 on ERK activation.
    Xu Y; Yang G; Hu G
    Acta Biochim Biophys Sin (Shanghai); 2009 Jun; 41(6):488-94. PubMed ID: 19499152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IFITM1 increases osteogenesis through Runx2 in human alveolar-derived bone marrow stromal cells.
    Kim BS; Kim HJ; Kim JS; You YO; Zadeh H; Shin HI; Lee SJ; Park YJ; Takata T; Pi SH; Lee J; You HK
    Bone; 2012 Sep; 51(3):506-14. PubMed ID: 22634173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pan-cancer EMT-signature identifies RBM47 down-regulation during colorectal cancer progression.
    Rokavec M; Kaller M; Horst D; Hermeking H
    Sci Rep; 2017 Jul; 7(1):4687. PubMed ID: 28680090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
    Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
    Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. h-Prune is associated with poor prognosis and epithelial-mesenchymal transition in patients with colorectal liver metastases.
    Hashimoto M; Kobayashi T; Tashiro H; Arihiro K; Kikuchi A; Ohdan H
    Int J Cancer; 2016 Aug; 139(4):812-23. PubMed ID: 27037526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cadherin-12 enhances proliferation in colorectal cancer cells and increases progression by promoting EMT.
    Ma J; Zhao J; Lu J; Wang P; Feng H; Zong Y; Ou B; Zheng M; Lu A
    Tumour Biol; 2016 Jul; 37(7):9077-88. PubMed ID: 26762412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer.
    Yan X; Yan L; Liu S; Shan Z; Tian Y; Jin Z
    Mol Med Rep; 2015 Aug; 12(2):2999-3006. PubMed ID: 25936636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer.
    Zhang Z; Liu X; Feng B; Liu N; Wu Q; Han Y; Nie Y; Wu K; Shi Y; Fan D
    Oncogene; 2015 Sep; 34(37):4808-20. PubMed ID: 25531324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant DNA methylation in the IFITM1 promoter enhances the metastatic phenotype in an intraperitoneal xenograft model of human ovarian cancer.
    Kim NH; Sung HY; Choi EN; Lyu D; Choi HJ; Ju W; Ahn JH
    Oncol Rep; 2014 May; 31(5):2139-46. PubMed ID: 24676393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha B-crystallin promotes the invasion and metastasis of colorectal cancer via epithelial-mesenchymal transition.
    Shi C; Yang X; Bu X; Hou N; Chen P
    Biochem Biophys Res Commun; 2017 Aug; 489(4):369-374. PubMed ID: 28506831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Octamer transcription factor 1 mediates epithelial-mesenchymal transition in colorectal cancer.
    Li Y; Dong M; Kong F; Zhou J
    Tumour Biol; 2015 Dec; 36(12):9941-6. PubMed ID: 26178483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of sirt7 exhibits oncogenic property and serves as a prognostic factor in colorectal cancer.
    Yu H; Ye W; Wu J; Meng X; Liu RY; Ying X; Zhou Y; Wang H; Pan C; Huang W
    Clin Cancer Res; 2014 Jul; 20(13):3434-45. PubMed ID: 24771643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.